Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas: A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG)
dc.authorscopusid | 37002887000 | |
dc.authorscopusid | 16203384500 | |
dc.authorscopusid | 57867202100 | |
dc.authorscopusid | 7005094713 | |
dc.authorscopusid | 7003953248 | |
dc.authorscopusid | 56348383300 | |
dc.authorscopusid | 6603070081 | |
dc.contributor.author | Kayikci, Omur | |
dc.contributor.author | Mehtap, Ozgur | |
dc.contributor.author | Sari, Ismail | |
dc.contributor.author | Demirkan, Fatih | |
dc.contributor.author | Beyan, Cengiz | |
dc.contributor.author | Cetin, Guven | |
dc.contributor.author | Vural, Filiz | |
dc.date.accessioned | 2023-01-12T20:16:53Z | |
dc.date.available | 2023-01-12T20:16:53Z | |
dc.date.issued | 2022 | |
dc.department | N/A/Department | en_US |
dc.description.abstract | Objective: Peripheral T-cell lymphomas (PTCLs) are an uncommon and quite heterogeneous group of disorders, representing only 10%-15% of all non-Hodgkin lymphomas. Although both molecular and clinical studies have increased in recent years, we still have little knowledge regarding real-life practice with PTCLs. In this study, we aimed to investigate the clinical characteristics and treatment outcomes of a large population-based cohort of patients presenting with systemic non-cutaneous PTCL. Materials and Methods: We conducted a multicenter retrospective analysis of 190 patients consecutively diagnosed and treated with non-cutaneous PTCLs between 2008 and 2016. Results: Considering all first-line treatment combinations, the overall response rate was 65.9% with 49.4% complete remission (n=81) and 16.5% partial response (n=27). The 5-year overall survival and event-free survival rates were significantly different between the transplant and non-transplant groups (p<0.01, and p=0.033, respectively). Conclusion: The retrospective analysis of a large volume of real-life data on the Turkish experience regarding non-cutaneous PTCL patients showed consistent results compared to other unselected PTCL cohorts with some minor differences in terms of survival and transplantation outcomes. The long-term outcome of patients who receive autologous hematopoietic cell transplantation as part of upfront consolidation or salvage therapy is favorable compared to patients who are unable to receive high-dose therapy. | en_US |
dc.identifier.doi | 10.4274/tjh.galenos.2022.2022.0052 | |
dc.identifier.endpage | 177 | en_US |
dc.identifier.issn | 1300-7777 | |
dc.identifier.issn | 1308-5263 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 35678126 | en_US |
dc.identifier.scopus | 2-s2.0-85137000431 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 170 | en_US |
dc.identifier.uri | https://doi.org/10.4274/tjh.galenos.2022.2022.0052 | |
dc.identifier.uri | https://hdl.handle.net/11454/78787 | |
dc.identifier.volume | 39 | en_US |
dc.identifier.wos | WOS:000883473800003 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Galenos Publ House | en_US |
dc.relation.ispartof | Turkish Journal of Hematology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Lymphomas | en_US |
dc.subject | Autologous stem cell transplantation | en_US |
dc.subject | T-cell lymphomas | en_US |
dc.subject | Non-Hodgkin lymphoma | en_US |
dc.subject | High-Dose Chemotherapy | en_US |
dc.subject | American Society | en_US |
dc.subject | Up-Front | en_US |
dc.subject | Transplantation | en_US |
dc.subject | Survival | en_US |
dc.subject | Guidelines | en_US |
dc.subject | Prognosis | en_US |
dc.subject | Disease | en_US |
dc.subject | Cohort | en_US |
dc.title | Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas: A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG) | en_US |
dc.title.alternative | Non-kutanöz Periferik T-hücreli Lenfomalarda Klinik Özellikler ve Tedavi Sonuçlarına ilişkin Gerçek Yaşam Deneyimi:Türk Hematoloji Araştırma ve Eğitim Grubunun Çok Merkezli Çalışması | en_US |
dc.type | Article | en_US |